Advertisement

Prostate Cancer Roundtable Company Profile

23:07 EDT 19th June 2013 | BioPortfolio


News Articles [ 2779 Associated News Articles listed on BioPortfolio]

New Legislation To Make USPSTF More Transparent: Prostate Cancer Roundtable Supports Reform

WASHINGTON, June 25, 2012 /PRNewswire/ -- The Prostate Cancer Roundtable commends Congressmen Marsha Blackburn and John Barrow for their introduction of H.R. 5998, the USPSTF Transparency and Acc...

Better Prostate Cancer Diagnosis - Image-Guided Biopsy

Magnetic resonance ultrasound fusion targeted biopsy is a better way to accurately diagnose prostate cancer, scientists from the University of California, Los Angeles, have found. Prostate cancer is t...

A Look At The Prostate Cancer Treatment Market

ByEmerging Equities:According to research firm RNCOS, the number of newly diagnosed global cancer cases is expected to reach over 17 million by 2020. The U.S. is the largest market for cancer drugs....

CEO Roundtable on Cancer recognizes UMB Financial with CEO Cancer Gold Standard

UMB Financial Corporation, a financial services holding company headquartered in Kansas City, MO, is leading by example when it comes to promoting workplace wellness and encouraging healthier behavior...

CEO Roundtable on Cancer recognizes efforts of Methodist Le Bonheur Healthcare

The CEO Roundtable on Cancer recently accredited Methodist Le Bonheur Healthcare with the CEO Cancer Gold Standard, recognizing the health care system's efforts to reduce the risk of cancer for their...

AstraZeneca launches prostate cancer app

AstraZeneca has launched a new app that helps prostate cancer patients to monitor their PSA levels. It is not the first PSA testing app and there are also other applications with the ability to commun...

Diagnosis of Prostate Cancer Uses Oncogene Molecular Signature

A diagnostic test distinguishes patients with clinically relevant prostate cancer from normal prostate in men with elevated prostate-specific...

Prostate cancer screening and the management of clinically localized disease

Summary pointsIncreasing age is the most important risk factor for developing prostate cancer The most effective way to reduce prostate cancer incidence is to reduce prostate specific antigen (PSA)......

Drugs and Medications [ 487 Associated Drugs and Medications listed on BioPortfolio]

Avodart [Preferred Pharmaceuticals, Inc]

These highlights do not include all the information needed to use AVODART safely and effectively. See full prescribing information for AVODART. AVODART (dutasteride) Soft Gelatin CapsulesInitial U.S....

Avodart [GlaxoSmithKline LLC]

These highlights do not include all the information needed to use AVODART safely and effectively. See full prescribing information for AVODART. AVODART (dutasteride) Soft Gelatin CapsulesInitial U.S....

Avodart [Physicians Total Care, Inc.]

These highlights do not include all the information needed to use AVODART safely and effectively. See full prescribing information for AVODART. AVODART (dutasteride) Soft Gelatin CapsulesInitial U.S....

Doxazosin [Apotex Corp.]

DOXAZOSIN TABLETS, USP 1 mg, 2 mg, 4 mg and 8 mg

Doxazosin mesylate tablets 1 mg, 2 mg, 4 mg, 8 mg (doxazosin) [Genpharm Inc.]

DOXAZOSIN MESYLATE TABLETS 1 mg, 2 mg, 4 mg, 8 mg (doxazosin)

PubMed Articles [ 2686 Associated PubMed Articles listed on BioPortfolio]

To screen or not to screen: ongoing debate in the early detection of prostate cancer.

Debate about the use of prostate-specific antigen (PSA) tests to screen prostate cancer in men is ongoing. Prostate cancer is the most common cancer after skin cancer in men and the second most deadly...

ERG rearrangement in local recurrences compared to distant metastases of castration-resistant prostate cancer.

Castration-resistant prostate cancer is the second most common cause of cancer death and results in a median survival of less than 2 years. In prostate cancer, fusions between TMPRSS2 and ERG are com...

Smoking and prostate cancer survival and recurrence.

Studies of smoking in relation to prostate cancer mortality or recurrence in prostate cancer patients are limited, with few prostate cancer-specific outcomes.

Modeling prostate cancer in mice: something old, something new, something premalignant, something metastatic.

More than 15 years ago, the first generation of genetically engineered mouse (GEM) models of prostate cancer was introduced. These transgenic models utilized prostate-specific promoters to express SV...

Early detection of prostate cancer : Is serum PSA testing alone sufficient?

The euphoria over PSA as an optimal marker for prostate cancer is gone. Measuring PSA levels has several deficiencies in detecting prostate cancer. First results of the randomized studies ERSPC and PL...

Clinical Trials [ 2809 Associated Clinical Trials listed on BioPortfolio]

Pilot Study of the National Colorectal Cancer Roundtable Toolbox (NCCRT) to Increase Colorectal Cancer Screening Rates

The American Cancer Society and The Centers for Disease Control and Prevention in collaboration with The National Colorectal Cancer Roundtable published "How to Increase Colorectal Cancer...

Vitamin E Supplements in Preventing Cancer in Patients at Risk of Prostate Cancer or Who Have Prostate Cancer

RATIONALE: Vitamin E supplements may stop or delay the development of prostate cancer in patients who are at risk of prostate cancer or who have prostate cancer. It is not yet known which...

Docetaxel and Diethylstilbestrol in the Treatment of Androgen Independent Prostate Cancer

This study is for men who have prostate cancer that has spread outside of the prostate gland and is no longer responding to hormone removal therapy. This study is designed to determine if...

Characterization of Prostate Cancer With 3T MR

The long-term goal of this proposal is to provide a pre-treatment evaluation that can assist in the rational selection of patients to undergo appropriate and definitive therapy for prostat...

Follow-Up Study for Men Diagnosed With Prostate Cancer Through Participation in a Prostate Specific Antigen Screening Program

There is controversy concerning the preferred treatment for men with localized prostate cancer with regard to the relative effectiveness of different treatments in controlling the cancer a...

Companies [ 1199 Associated Companies listed on BioPortfolio]

Prostate Cancer Roundtable

Prostate Cancer Foundation

The Prostate Cancer Foundation (PCF) is the world’s largest philanthropic source of support for accelerating the world’s most promising research for discovering better t...

The Prostate Cancer Foundation

The Prostate Cancer Foundation is the world’s largest philanthropic source of support for prostate cancer research focused on discovering better treatments and a cure for pro...

Prostate Cancer Education Council

Prostate cancer remains the second-leading cause of cancer death in American men. More than 220,000 men will be diagnosed with prostate cancer this year and it is expected that 27,000 men will die fro...

The CEO Roundtable on Cancer

The CEO Roundtable on Cancer was founded in 2001, when former President George H.W. Bush challenged a group of executives to "do something bold and venturesome about cancer within...

More Information about "Prostate Cancer Roundtable" on BioPortfolio

We have published hundreds of Prostate Cancer Roundtable news stories on BioPortfolio along with dozens of Prostate Cancer Roundtable Clinical Trials and PubMed Articles about Prostate Cancer Roundtable for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Prostate Cancer Roundtable Companies in our database. You can also find out about relevant Prostate Cancer Roundtable Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement